Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma

Leukemia. 2013 Jan;27(1):252-5. doi: 10.1038/leu.2012.172. Epub 2012 Jun 26.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Female
  • Humans
  • Lymphoma, Follicular / drug therapy*
  • Lymphoma, Large B-Cell, Diffuse / drug therapy*
  • Male